Home Trending Stocks Why Second Sight Medical Products, Inc. (EYES) stock is Popping High today?

Why Second Sight Medical Products, Inc. (EYES) stock is Popping High today?

Second Sight Medical Products, Inc. (EYES) stock announced two-year results of its Orion Study after which the EYES stock price happened to be green today on May 12, 2021, and saw a surge of 8.40% to reach $5.42 a share as of this writing. EYES stock was gloomy during the previous trading session and went down by 3.10% at closing. Let’s discuss the recent news in detail.

Get the hottest stocks to trade every day before the market opens 100% ‎free. Click here now. 

Orion Study Results:

Orion Visual Cortical Prosthesis (Orion) is the feasibility study of an implanted cortical stimulation device that is created for blind individuals in order to provide them useful artificial vision.

5 Stocks Under $10 That Are Poised to Take Off

Investing in stocks under $10 could significantly increase the returns on your portfolio, especially if you pick the right stocks! Within this report you will find 5 top stocks that offer investors huge upside potential and the best bang for their buck.

Add them to your watchlist before they take off!

Get the Top 5 Stocks Now!

Sponsored

Read More

The study took place at UCLA and Baylor College of Medicine and the results showed that most of the participants involved in it benefited from the Orion  Visual Cortical Prosthesis system. Five out of Five individuals by using the Orion system were able to locate the white square on the dark computer screen significantly which was not that much easy without Orion System. Four out of five tested in the two-year study were able to easily identify the direction of moving motion bar across the screen of computer by using the Orion System.

COVID-19 impact:

The governmental COVID-19 restrictions had paused the study for some time at both study centers but now it is proceeding at both centers. The Functional Low-Vision Observer Rated Assessment (FLORA)  was limited to two subjects due to travel restriction caused by COVID-19, but both received a positive benefit from Orion. The study in the early stage resulted one serious event which was coped without hospitalization.

Previous Activities by Second Sight:

On April 6, 2021, EYES stock announced the appointment of two new members, Dr. Dean Baker and Ms. Alexandra Larson to its board of directors. Dr. Dean Baker was also appointed to the Audit Committee of the Board. The chairman of the Board welcomed both members and expressed excitement by acknowledging the talent and experience of both new members. Prior to this announcement, Second Sight’s Board of Directors had named Scott Dunbar as an acting Chief Executing Officer for one year.

Get the hottest stocks to trade every day before the market opens 100% ‎free. Click here now. 

Conclusion:

The recent news related to the two-year feasibility study of the Orion system by the EYES stock has forced the investors to respond accordingly. The management is excited to resume the study to further analyze the promising results and ease in COVID-19 restriction due to roll out of vaccine is a good sign for EYES stock. In short, investors need to keep an eye on it.

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Must Read

Tyme Technologies, Inc. (TYME) Stock Trends downwards Following Strong Q4 2021 Financials and Progress in OASIS Trial

Tyme Technologies, Inc. (TYME) stock prices was down by -6.92% shortly after market trading commenced on June 11th, 2021, bringing the price per share...

Prophase Labs Inc. (PRPH) stock surged during pre-market trading session. Let’s figure out why?

Prophase Labs Inc. (NASDAQ: PRPH) stock soared by 5.87% at last close as well as the PRPH stock price has been observed rising by...

Why Surgalign Holdings, Inc. (SRGA) stock is gloomy today?

Surgalign Holdings, Inc. (SRGA) stock announced the $50 million registered direct offering priced at the market under Nasdaq rules today on June 10, 2021,...

Exela Technologies Inc. (XELA) stock soars during pre-market. Here’s what you should know?

Exela Technologies Inc. (NASDAQ: XELA) stock gained by 8.28% at last close while the XELA stock price rises in the pre-market as well, by...

Atossa Therapeutics, Inc. (ATOS) stock gains during pre-market trading. Here’s to know why?

Atossa Therapeutics, Inc. (NASDAQ: ATOS) stock declined by 27.51% at the last close while the ATOS stock price rises further by 9.09% in the...

Magnachip Semiconductor Corporation (MX) stock is Popping High today: Why is it so?

Shares of the Magnachip Semiconductor Corporation (MX) stock were popping high after the announcement of its receival of unsolicited buyout bid from Cornucopia Investment...

Why is Autolus Therapeutics plc (AUTL) stock rising today?

Shares of  Autolus Therapeutics plc (AUTL) stock were rising today on June 11, 2021, following the release of the presentation data related to obe-cel...

Mustang Bio, Inc. (MBIO) stock is climbing today: Here is to know why.

Mustang Bio, Inc. (MBIO) stock announced the updated interim data from Phase 1/2 clinical trial of its MB-106 CD20-targeted, autologous CAR T today on...

Related News

Tyme Technologies, Inc. (TYME) Stock Trends downwards Following Strong Q4 2021 Financials and Progress in OASIS Trial

Tyme Technologies, Inc. (TYME) stock prices was down by -6.92% shortly after market trading commenced on June 11th, 2021, bringing the price per share...

Prophase Labs Inc. (PRPH) stock surged during pre-market trading session. Let’s figure out why?

Prophase Labs Inc. (NASDAQ: PRPH) stock soared by 5.87% at last close as well as the PRPH stock price has been observed rising by...

Why Surgalign Holdings, Inc. (SRGA) stock is gloomy today?

Surgalign Holdings, Inc. (SRGA) stock announced the $50 million registered direct offering priced at the market under Nasdaq rules today on June 10, 2021,...

Exela Technologies Inc. (XELA) stock soars during pre-market. Here’s what you should know?

Exela Technologies Inc. (NASDAQ: XELA) stock gained by 8.28% at last close while the XELA stock price rises in the pre-market as well, by...

Atossa Therapeutics, Inc. (ATOS) stock gains during pre-market trading. Here’s to know why?

Atossa Therapeutics, Inc. (NASDAQ: ATOS) stock declined by 27.51% at the last close while the ATOS stock price rises further by 9.09% in the...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

We do not sell or share your information with anyone.

Get Notified Of Insider Trades, Analyst Upgrades & Downgrades, Earnings Updates & Best Stocks To Trade Every Single Morning

100% free. stop anytime no spam